In accordance with reference to the circulars issued by Exchange through Circular no. LIST/CaMP/01/2019-20 and Exchange vide Circular no. NSE/CML/2019/11 dated April 2, 2019 and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and in terms of Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, Panjon has informed that the Trading window for dealing in securities/ shares of the Company will remain closed for all the Designated Persons and their immediate relatives of the Company with immediate effect, from Wednesday, April 01, 2020 until 48 hours after the announcement of the audited financial results of the Company for the quarter and year ended 31st March, 2020. The Board meeting for approving the audited financial results for the quarter and year ended 31st March, 2020 will be held on or before 30th June, 2020 as per the SEBI vide Circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/38 dated 19th March, 2020. Accordingly, all Designated Persons and their immediate relatives have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
The above information is a part of company's filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |